CADL – candel therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Candel Therapeutics, Inc. (NASDAQ: CADL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, up previously from $11.00.
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Candel Therapeutics Announces Pricing of Public Offering
Candel Therapeutics Announces $80 Million Proposed Public Offering
Candel Therapeutics stock up 172% after Phase III prostate cancer success [Yahoo! Finance]
Form 4 Candel Therapeutics, For: Dec 16 Filed by: Manning Paul B
Form SC 13G Candel Therapeutics, Filed by: CVI Investments, Inc.
Form 4 Candel Therapeutics, For: Dec 11 Filed by: Aguilar Laura K.
Form 8-K Candel Therapeutics, For: Dec 12
Form 424B5 Candel Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.